Individuals with serious mental illness who have committed major crimes pose a unique problem for balancing the clinical needs of the patient against the protection of the public. A 2011 summary of studies from 10 developed countries suggests that the US does a poor job in this task; recidivism for individuals with psychotic disorders was twice as high in the US compared with 9 other countries.1 We undertook a state survey of forensic practices to ascertain why the US does so poorly.
Treat or Repeat: A State Survey of Serious Mental Illness, Major Crimes and Community Treatment, released September 19 by the Treatment Advocacy Center, is the result.2 In the first such study, surveys and interviews were conducted with mental health and correction officials in each state to determine what laws, policies, and programs are used to decrease recidivism for individuals with serious mental illnesses who are released from jails or prisons or discharged from hospitals. States were graded A, B, C, D, or F on their efforts. Overall grades reflect whether the state has adopted enumerated evidence-based laws or programs so that they are theoretically available for the target population. Analysis of implementation, either in the quality of the programming or the uniformity of service availability throughout a state, was beyond the scope of this report.
The results were less than encouraging and help to explain why the US lags behind other countries in this regard. No state received an A, but 4 states—Hawaii, Maine, Missouri, and Oregon—achieved a B+. On the other end of the spectrum, Alaska, Idaho, Indiana, Massachusetts, Mississippi, New Mexico, Texas, and Wyoming were graded F. It should be emphasized that the grades reflect states’ efforts only for this specific population of patients; for other patient populations, the state may do better or worse. We emphasize that the grade is a composite, since programs often vary widely among counties, especially in large states. The grade reflects what is theoretically available for a program within the state without the need for legislative or policy change.
How to decrease recidivism
The good news from this state survey is that programs were identified in many states that can be used as models to improve outcomes for this patient population. For individuals with serious mental illness who have committed major crimes, past studies have shown that if they do not continue treatment when they are placed in the community, their re-arrest rate is 40% to 60% within 5 years. However, if such individuals maintain treatment upon community reentry, their re-arrest rate can be reduced to 10% or lower.
The most widely used effective treatment is conditional release. This requires that individuals who live in the community follow a treatment plan or be subject to possible rehospitalization. The states with the largest number of individuals on conditional release per population are Hawaii, Arkansas, and Maryland. Follow-up studies of conditional release in California, Connecticut, Maryland, and Virginia have shown it to be highly effective in reducing recidivism. Conditional release is available in all states except Idaho, Indiana, Massachusetts, New Mexico, North Carolina, Pennsylvania, and Texas—all of which were graded D or F.
A second effective mechanism for reducing recidivism in individuals with serious mental illness living in the community is the creation of psychiatric security review boards (PSRBs). Pioneered in Oregon and Connecticut, these review boards centralize the authority for the release of and follow-up for forensic patients in a single small group of people. The Oregon PSRB, for example, consists of a psychiatrist, psychologist, lawyer, parole or probation officer, and member of the public appointed by the governor to 4-year terms. Virtually all individuals found not guilty by reason of insanity (NGRI) are assigned to the PSRB, which has full authority over the individual, including duration of inpatient care, conditional release, and discharge. Follow-up studies of PSRBs have shown them to be highly effective. Many states have a body that operates similarly, but the best results have been achieved where the legislature has created such a centralized authority.
Dr. Torrey is a research psychiatrist who specializes in schizophrenia and bipolar disorder. He is Founder of the Treatment Advocacy Center, Associate Director of the Stanley Medical Research Institute, and the author of American Psychosis: How the Federal Government Destroyed the Mental Illness Treatment System. Ms. Dailey is a legislative and policy counsel at the Treatment Advocacy Center. She is a lawyer and has a master’s degree in International Human Rights.
1. Fazel S, Yu R. Psychotic disorders and repeat offending: systematic review and meta-analysis. Schiz Bull. 2011;37:800-810.
2. Torrey EF, Dailey L, Lamb HR, et al. Treat or Repeat: A State Survey of Serious Mental Illness, Major Crimes and Community Treatment. Treatment Advocacy Center. September 2017. http://www.treatmentadvocacycenter.org/treat-or-repeat. Accessed October 6, 2017.
3. Lamberti JS, Weisman RL, Cerulli C, et al. A randomized controlled trial of the Rochester Forensic Assertive Community Treatment Model. Psychiatr Serv. 2017;68:1016-1024.
4. Frankle WG, Shera D, Berger-Hershkowitz H, et al. Clozapine-associated reduction in arrest rates of psychotic patients with criminal histories. Am J Psychiatry. 2001;158:270-274.
5. Torrey EF, Knable MB, Quanbeck C, et al. Clozapine for Treating Schizophrenia: A Comparison of the States. Treatment Advocacy Center. November 2015. http://www.treatmentadvocacycenter.org/storage/documents/clozapine-for-treating-schizophrenia.pdf. Accessed October 6, 2017.